Viewing StudyNCT05252988



Ignite Creation Date: 2024-05-06 @ 5:17 PM
Last Modification Date: 2024-10-26 @ 2:25 PM
Study NCT ID: NCT05252988
Status: RECRUITING
Last Update Posted: 2023-12-15
First Post: 2022-02-02

Brief Title: Three Antidiarrheal Strategies in HER2HR Early Breast Cancer Patients Treated With Extended Adjuvant Neratinib
Sponsor: Spanish Breast Cancer Research Group
Organization: Spanish Breast Cancer Research Group

Organization Data

Organization: Spanish Breast Cancer Research Group
Class: OTHER
Study ID: GEICAM2018-06
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Spanish Breast Cancer Research Group
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Pierre Fabre Laboratories INDUSTRY
Puma Biotechnology Inc INDUSTRY